Skip Page Header

Home > New heroin-assisted treatment. Recent evidence and current practices of supervised injectable heroin treatment in Europe and beyond.

Strang, John and Groshkova, Teodora and Metrebian, Nicola (2012) New heroin-assisted treatment. Recent evidence and current practices of supervised injectable heroin treatment in Europe and beyond. Lisbon: European Monitoring Centre for Drugs and Drug Addiction.

[img] PDF (New heroin-assisted treatment) - Published Version
1MB
[img]
Preview
PDF (Drug and Alcohol Findings editorial and summary of report) - Supplemental Material
71kB

The prescription of substitution drugs, such as methadone and buprenorphine, has become a mainstream, first-line treatment for opioid dependence, with around 700 000 of Europe’s 1.3 million problem opioid users receiving substitution treatment today. But a small minority of entrenched opioid users repeatedly fails to respond to interventions of this kind. Findings from international trials now suggest that the supervised use of medicinal heroin can be an effective second-line treatment for this small, and previously unresponsive, group. In this latest EMCDDA Insights report, experts describe the development as ‘an important clinical step forward’. The report provides the first state-of-the-art overview of research on the subject, examining the latest evidence and clinical experience in this area in Europe and beyond.


Repository Staff Only: item control page